Key takeaways
- Lilly's self-pay Zepbound price runs from $299 to $699 for a 28-day KwikPen supply, depending on dose (read October 16, 2026).
- The $299 starting price applies to the KwikPen or vial, not the Zepbound single-dose pen.
- We found no published national med spa price, so the clinic total has to come from written quotes.
- Deep discounts that seem too good to be true are on FDA's red-flag list for GLP-1 sellers, and compounded drugs are not FDA-approved.
How much does tirzepatide cost per month?
The monthly number starts with the dose, because Zepbound is dosed in steps and Lilly charges a different self-pay price for each strength.
Under the Zepbound label, treatment starts at 2.5 mg once weekly for 4 weeks — a starter dose only, not a maintenance dose — then moves to 5 mg, rising in 2.5 mg steps after at least 4 weeks on each dose.
Maintenance doses for weight reduction are 5 mg, 10 mg or 15 mg once weekly, and the maximum dose is 15 mg.
Lilly's posted self-pay prices, read October 16, 2026, for a 1-month (28-day) supply of the Zepbound single-patient-use KwikPen:
| Dose (once weekly) | Lilly self-pay price |
|---|---|
| 2.5 mg (starter) | $299 |
| 5 mg | $399 |
| 7.5 mg | $499 |
| 10 mg, 12.5 mg or 15 mg | $699 |
Lilly also lists a $449 purchase offer for the 7.5, 10, 12.5 and 15 mg strengths if each refill is bought within 45 days of the previous one.
The $299 starting price also covers 4 vials at 2.5 mg; Lilly's separately posted vial price list for the higher strengths was not reachable when this was checked, so the figures in the table are the KwikPen prices.
Form matters to price.
Lilly states the $299-per-month starting price applies to the KwikPen or the vial, not the Zepbound single-dose pen; with commercial insurance that does not cover Zepbound, the single-dose pen can cost as low as $499 per month with Lilly's savings card.
Zepbound now comes as single-dose pens, single-dose vials and — since a January 2026 label change — multi-dose vials and a 4-dose single-patient-use KwikPen, which the label says must never be shared between patients, even with a new needle.
None of these figures is a med spa price: we could not confirm a national average for what a med spa or weight-loss clinic charges for the program around the drug from published sources, so the monthly total has to come from each provider's quote.
These are Lilly's own self-pay prices, read October 16, 2026. Per the card terms Lilly posted, savings run through December 31, 2026, taxes and fees may apply, and government beneficiaries are excluded from the commercial savings card. Lilly can change prices at any time.
Clinic vs LillyDirect vs insurance
Zepbound is a prescription drug: it requires a valid prescription from a licensed prescriber, and FDA tells patients to fill prescriptions at state-licensed pharmacies.
Zepbound (tirzepatide, Eli Lilly) is FDA-approved, with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain the reduction long term in adults with obesity, or adults with overweight plus at least one weight-related condition, and to treat moderate to severe obstructive sleep apnea in adults with obesity — what it is approved for and how it is dosed are in our tirzepatide guide.
Whether a plan covers Zepbound, and at what tier, is a question for the plan itself.
Buying through Lilly's self-pay program (LillyDirect) takes insurance out of the equation for the medication: the price is the dose-based figure in the table above, and Lilly says the single-dose pen route runs as low as $499 per month with its savings card when a commercial plan does not cover Zepbound.
On Medicare, Lilly's Zepbound page mentions a "Medicare GLP-1 Bridge" for eligible Part D patients prescribed Zepbound for weight management, based on what Lilly's page calls "Medicare GLP-1 Bridge Clinical Criteria".
We could not verify that program's details or dollar caps, so treat it as something to ask about rather than a confirmed price.
A med spa or weight-loss clinic sits between those two: you pay the provider, and what the fee covers beyond the medication is exactly what to pin down — ask for the total monthly cost and what it includes.
Three ways to pay
| Route | What sets the price | What to confirm |
|---|---|---|
| Lilly self-pay (LillyDirect) | Lilly's dose-based price | Which form: KwikPen or vial, or the single-dose pen |
| Insurance | Your plan | Whether the plan covers Zepbound, and at what tier |
| Med spa or clinic | The provider's fee | The total monthly cost and what it includes |
Who may prescribe is also a state question: whether a nurse practitioner can evaluate, diagnose and prescribe independently depends on the state, which the American Association of Nurse Practitioners classifies as Full, Reduced or Restricted Practice.
We walk through the rules in who can prescribe GLP-1s.
Why cheap offers are risky
The offers that undercut every figure above are the ones to slow down for, because deep discounts are on FDA's red-flag list for GLP-1 sellers.
Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness or quality before they are marketed; the agency says compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug.
FDA's red flags for GLP-1 sellers include claiming a compounded drug is the same as an FDA-approved drug, deep discounts that seem too good to be true, no screening and prescription by a licensed doctor, no doctor available for questions, label spelling errors or wrong pharmacy addresses, and a pharmacy name you suspect is fraudulent.
The shortage rationale behind cheap compounded offers is also over: FDA declared the tirzepatide shortage resolved on October 2, 2024 and reaffirmed that on December 19, 2024, and as of the agency's April 1, 2026 update, tirzepatide is not on FDA's drug shortage list or its 503B bulks list, so 503B outsourcing facilities generally may not compound it from bulk drug substance.
Compounding has not ended: under FDA's 503A rules, a compounded GLP-1 with the same active ingredient in a similar strength and route as the approved drug is treated as an "essentially copy" unless the prescriber determines and documents that a change produces a significant difference for an identified individual patient.
The FDA rules behind cheap compounded GLP-1 offers, and what changed when the shortages ended, are covered in compounded semaglutide and tirzepatide.
As of May 31, 2026, FDA had received more than 730 adverse-event reports tied to compounded tirzepatide and 990 tied to compounded semaglutide, counts the agency says are likely underreported. FDA's July 2024 alert described compounded semaglutide dosing errors, some needing hospitalization, after patients drew 5 to 20 times the intended dose from multi-dose vials.
Find tirzepatide providers near you
Compare Google ratings, reviews and posted prices at med spas in your city.
Price in your city
We found no national med spa price for tirzepatide to look up from published sources, and the only figures we can confirm are Lilly's own self-pay prices above.
What a program in your city charges, what it dispenses — the branded KwikPen or vials at Lilly's posted prices, or something else — and what its fee covers are the three things a written quote should state.
A quote that undercuts Lilly's posted prices by a lot looks like the "deep discounts that seem too good to be true" red flag on FDA's list, and the question to ask is which product it is and who made it.
Dose changes move the price: ask what each step up the Zepbound label's ladder would cost per month, not just the 2.5 mg starter figure.
Get quotes near you
We found no published clinic pricing, so the practical move is to put the same questions to several providers and compare the totals in writing.
- Which product exactly — brand-name Zepbound or a compounded preparation — and who made it?
- Where is the prescription filled? FDA tells patients to fill prescriptions at state-licensed pharmacies.
- The total monthly cost at the starting dose, at each step up, and at maintenance — and what the program fee covers beyond the medication.
- Who prescribes — and if it is a nurse practitioner, whether they can prescribe independently in this state, which the American Association of Nurse Practitioners says depends on the state.
- Whether any part of the pitch matches FDA's red-flag list: sameness claims, too-good-to-be-true discounts, no screening or prescription by a licensed doctor.
Nothing here is a recommendation to start tirzepatide or a prediction of what you will pay: the figures above are dated manufacturer prices, and your own cost depends on your prescription, your dose and your insurance situation.
For the medical questions — whether the treatment fits you, and at what dose — a licensed provider is the one who can answer for your case.
Frequently asked questions
How much is tirzepatide per month without insurance?
The figures we can confirm are Lilly's self-pay prices, read October 16, 2026: $299 for a 28-day supply of the Zepbound KwikPen at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg and $699 at 10, 12.5 or 15 mg, with a $449 offer for the 7.5 to 15 mg strengths when each refill is bought within 45 days.
For med spas and clinics we could not confirm a national average, so ask each provider for the monthly total.
Why is some tirzepatide so much cheaper?
Because deep discounts are on FDA's red-flag list for GLP-1 sellers.
Compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality, and FDA's red flags for GLP-1 sellers include deep discounts that seem too good to be true and claims that a compounded drug is the same as an FDA-approved drug.
Ask any provider exactly which product you would get and who made it before you pay.
Does insurance cover tirzepatide at a med spa?
Coverage is a question for your plan.
Lilly states that with commercial insurance that does not cover Zepbound, the single-dose pen can cost as low as $499 per month with its savings card.
Lilly's page also mentions a Medicare GLP-1 Bridge for eligible Part D patients prescribed Zepbound for weight management, but we could not verify that program's details or dollar caps, so treat it as something to ask your plan about and confirm with Medicare.
Why does the price of tirzepatide change over time?
Because the dose changes.
The Zepbound label starts at 2.5 mg once weekly for 4 weeks, then 5 mg, rising in 2.5 mg steps after at least 4 weeks on each dose, with maintenance at 5, 10 or 15 mg.
Lilly's self-pay price rises with the dose, from $299 to $699 for a 28-day KwikPen supply, so the monthly cost at the start is not the monthly cost at maintenance.
Sources
Every number on this page comes from one of these sources and was checked against it.
- pi.lilly.com · pi.lilly.com
- CDER Update · U.S. Food and Drug Administration
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · U.S. Food and Drug Administration
- FDA alerts health care providers, compounders of dosing errors · U.S. Food and Drug Administration
- zepbound.lilly.com · zepbound.lilly.com
- State Practice Environment · aanp.org
Medical disclaimer. MedSpaStandard is for education only and is not medical advice. Talk to a licensed provider about your own health, and check any provider's license with your state board.